SCHEMBL9602863

SCHEMBL9602863

C[SiH](C)OC(Cc1ccncc1)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP19A1 P11511 3/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
LOXL2 Q9Y4K0 2/20 0.32
ALDH1A1 P00352 2/20 0.31
CYP2D6 P10635 1/20 0.31
HSD17B10 Q99714 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871994 0.79 MME (0.37)
SCHEMBL5872189 0.77 MEN1 (0.39)
SCHEMBL5871216 0.77 PPARA (0.40) ALDH1A1
SCHEMBL9602332 0.77 PDE4A (0.35)
SCHEMBL8545986 0.76 CYP2A6 (0.42) CYP19A1LOXL2ALDH1A1HSD17B10RAB9A
SCHEMBL9602656 0.75 CTSK (0.33)
SCHEMBL8880541 0.71 ESR1 (0.38) CYP3A4CYP2C9CYP2C19ALDH1A1HSD17B10
SCHEMBL4058750 0.70 ACACB (0.40) CYP3A4CYP19A1ALDH1A1RAB9A
SCHEMBL19522791 0.70 CYP3A4 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19CYP19A1
SCHEMBL8686886 0.69 NPC1 (0.40) CYP2D6RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5217963-A Antiischemic, antiepileptic agent CIBA-GEIGY CORPORATION (US) 1993-06-08 US disclosed
US-5057506-A Anticonvulsants, antispasmodic and antischemic agents CIBA-GEIGY CORPORATION (US) 1991-10-15 US disclosed
US-4906621-A Certain 2-carboxypiperidyl-alkylene phosphonic acids and esters thereof useful for the treatment of disorders responsive to N-methyl-D-aspartate receptor blockade CIBA-GEIGY CORPORATION (US) 1990-03-06 US disclosed